Chi Meng

875 citations

41 papers · 661 indexed · h-index 16

Impact in

Pharmacology top 10%
- Piperaceae Chemical and Biological Studies
Toxicology top 10%

Papers in ⓘ

Pharmacology 6
- Piperaceae Chemical and Biological Studies 6
Microbiology 2

Co-authors: Yong Ling (22 shared papers)Jianqiang Qian (17 shared papers)Zhongyuan Xu (12 shared papers)Peng Zhu (9 shared papers)Chang‐Chun Ling (8 shared papers)Guonian Wang (6 shared papers)Jinlei Peng (1 shared paper)Fude Feng (2 shared papers)
Journals: European Journal of Medicinal Chemistry (5 papers)Journal of Natural Products (3 papers)Theranostics (2 papers)Molecules (2 papers)Journal of Medicinal Chemistry (2 papers)
Partner nations: China Macao United States

In The Last Decade

Chi Meng

39 papers receiving 654 citations

Peers

Countries citing papers authored by Chi Meng

Since Specialization

Citations

This map shows the geographic impact of Chi Meng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chi Meng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chi Meng more than expected).

Fields of papers citing papers by Chi Meng

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Chi Meng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chi Meng. The network helps show where Chi Meng may publish in the future.

Co-authors

The 25 scholars most cited alongside Chi Meng, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Chi Meng Line = papers co-authored together Chi Meng links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 41 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	Excellent antitumor and antimetastatic activities based on novel coumarin/pyrazole oxime hybrids European Journal of Medicinal Chemistry ·Hong Dai, Meiling Huang, Jianqiang Qian, Ji Liu, Chi Meng, Yangyang Li, Guxu Ming, Ting Zhang, Senling Wang, Yujun Shi, Yong Yao, Shushan Ge, Yanan Zhang, Yong Ling	2019	51
2	Recent advances for enhanced photodynamic therapy: from new mechanisms to innovative strategies Chemical Science ·Xia Wang, Jinlei Peng, Chi Meng, Fude Feng	2024	51
3	Overview of piperlongumine analogues and their therapeutic potential European Journal of Medicinal Chemistry ·Peng Zhu, Jianqiang Qian, Zhongyuan Xu, Chi Meng, Weizhong Zhu, Fansheng Ran, Wei Zhang, Yanan Zhang, Yong Ling	2021	44
4	β-Carboline and N-hydroxycinnamamide hybrids as anticancer agents for drug-resistant hepatocellular carcinoma European Journal of Medicinal Chemistry ·Yong Ling, Weijie Gao, Chang‐Chun Ling, Ji Liu, Chi Meng, Jianqiang Qian, Siqun Liu, Huiling Gan, Hongmei Wu, Jinhua Tao, Hong Dai, Yanan Zhang	2019	39
5	Hydroxamic Acid Derivatives of β-Carboline/Hydroxycinnamic Acid Hybrids Inducing Apoptosis and Autophagy through the PI3K/Akt/mTOR Pathways Journal of Natural Products ·Yong Ling, Yangyang Li, Rui Zhu, Jianqiang Qian, Ji Liu, Weijie Gao, Chi Meng, Jiefei Miao, Biao Xiong, Xiaodong Qiu, Chang‐Chun Ling, Hong Dai, Yanan Zhang	2019	36
6	Recent Advances in Multi-target Drugs Targeting Protein Kinases and Histone Deacetylases in Cancer Therapy Current Medicinal Chemistry ·Yong Ling, Ji Liu, Jianqiang Qian, Chi Meng, Jing Guo, Weijie Gao, Biao Xiong, Chang‐Chun Ling, Yanan Zhang	2020	34
7	Dexmedetomidine promotes breast cancer cell migration through Rab11-mediated secretion of exosomal TMPRSS2 Annals of Translational Medicine ·Chi Meng, Xiaoding Shi, Xing Huo, Xiaohong Wu, Pinyi Zhang, Guonian Wang	2020	34
8	Piperlonguminine and Piperine Analogues as TrxR Inhibitors that Promote ROS and Autophagy and Regulate p38 and Akt/mTOR Signaling Journal of Natural Products ·Peng Zhu, Jianqiang Qian, Zhongyuan Xu, Chi Meng, Ji Liu, Wenpei Shan, Weizhong Zhu, Yongjun Wang, Yumin Yang, Wei Zhang, Yanan Zhang, Yong Ling	2020	31
9	Development of pH/Glutathione-Responsive Theranostic Agents Activated by Glutathione S-Transferase π for Human Colon Cancer Journal of Medicinal Chemistry ·Ji Liu, Xin Liu, Jianqiang Qian, Chi Meng, Peng Zhu, Jiaying Hang, Yaling Wang, Biao Xiong, Xiaodong Qiu, Weizhong Zhu, Yumin Yang, Yanan Zhang, Yong Ling	2020	25
10	Pillar[6]arene-Based Supramolecular Nanocatalysts for Synergistically Enhanced Chemodynamic Therapy by the Intracellular Cascade Reaction ACS Applied Materials & Interfaces ·Xin Liu, Ji Liu, Chi Meng, Peng Zhu, Xiao Liu, Jianqiang Qian, Shijia Ling, Yanan Zhang, Yong Ling	2021	24
11	Recent development of BTK-based dual inhibitors in the treatment of cancers European Journal of Medicinal Chemistry ·Fansheng Ran, Yun Liu, Zhongyuan Xu, Chi Meng, Dezhi Yang, Jianqiang Qian, Xuexian Deng, Yanan Zhang, Yong Ling	2022	23
12	A random forest-based metabolic risk model to assess the prognosis and metabolism-related drug targets in ovarian cancer Computers in Biology and Medicine ·Haoxin Zhang, Chi Meng, Dongqing Su, Yuqiang Xiong, Haodong Wei, Yu Yao, Yongchun Zuo, Lei Yang	2022	23
13	Design and synthesis of benzylidenecyclohexenones as TrxR inhibitors displaying high anticancer activity and inducing ROS, apoptosis, and autophagy European Journal of Medicinal Chemistry ·Jianqiang Qian, Zhongyuan Xu, Chi Meng, Ji Liu, Pei‐Ling Hsu, Yangyang Li, Weizhong Zhu, Yumin Yang, Susan L. Morris‐Natschke, Kuo‐Hsiung Lee, Yanan Zhang, Yong Ling	2020	23
14	Activation of PI3K–Akt through taurine is critical for propofol to protect rat cardiomyocytes from doxorubicin-induced toxicity Canadian Journal of Physiology and Pharmacology ·Xuechao Sun, Jing Gu, Chi Meng, Mingming Li, Lei Shi, Guonian Wang	2013	23
15	Acidic tumor microenvironment-activatable fluorescent diagnostic probe for the rapid identification and resection of human tumors via spraying Biosensors and Bioelectronics ·Ji Liu, Zhongyuan Xu, Chi Meng, Sainaiwaiergul Wusiman, Xudong Xie, Yichen Wang, Xiao Feng, Chunyan Gu, Jun Chen, Chang‐Chun Ling, Peng Li, Zhenwei Yuan, Yong Ling	2023	18
16	A Derivative of Piperlongumine and Ligustrazine as a Potential Thioredoxin Reductase Inhibitor in Drug-Resistant Hepatocellular Carcinoma Journal of Natural Products ·Jianqiang Qian, Zhongyuan Xu, Peng Zhu, Chi Meng, Yun Liu, Wenpei Shan, Ang He, Yipeng Gu, Fansheng Ran, Yanan Zhang, Yong Ling	2021	17
17	Novel Phenylmethylenecyclohexenone Derivatives as Potent TrxR Inhibitors Display High Antiproliferative Activity and Induce ROS, Apoptosis, and DNA Damage ChemMedChem ·Xiaomei Wang, Jianqiang Qian, Peng Zhu, Rong Hua, Liu Ji, Jiaying Hang, Chi Meng, Wenpei Shan, Jiefei Miao, Yong Ling	2020	13
18	Effects of coadministration of low dose cannabinoid type 2 receptor agonist and morphine on vanilloid receptor 1 expression in a rat model of cancer pain Molecular Medicine Reports ·Mingyue Zhang, Chi Meng, Huichao Zou, Songyu Tian, Zhaodi Zhang, Guonian Wang	2017	13
19	<p>Upregulation of μ-Opioid Receptor in the Rat Spinal Cord Contributes to the α2-Adrenoceptor Agonist Dexmedetomidine-Induced Attenuation of Chronic Morphine Tolerance in Cancer Pain</p> Journal of Pain Research ·Pinyi Zhang, Jianlong Bu, Xiaohong Wu, Lin Deng, Chi Meng, Chao Ma, Xiaoding Shi, Guonian Wang	2020	13
20	GSH/ROS Dual-Responsive Supramolecular Nanoparticles Based on Pillar[6]arene and Betulinic Acid Prodrug for Chemo–Chemodynamic Combination Therapy Molecules ·Peng Zhu, Weidan Luo, Jianqiang Qian, Chi Meng, Wenpei Shan, Zhongyuan Xu, Wei Zhang, Xin Liu, Yong Ling	2021	13

About Chi Meng

Chi Meng is a scholar working on Pharmacology, Pharmacology, Microbiology, Molecular Biology and Toxicology, having authored 41 papers that have together received 661 indexed citations. Recurring topics across this work include Nanoplatforms for cancer theranostics (11 papers), Piperaceae Chemical and Biological Studies (6 papers), Histone Deacetylase Inhibitors Research (6 papers), Luminescence and Fluorescent Materials (4 papers), Protein Degradation and Inhibitors (3 papers), Pain Mechanisms and Treatments (3 papers), Photodynamic Therapy Research Studies (3 papers) and Peptidase Inhibition and Analysis (3 papers). The work is most often cited by research in Pharmacology (58 citations), Toxicology (22 citations), Organic Chemistry (158 citations), Biochemistry (29 citations) and Biomaterials (51 citations). Chi Meng has collaborated with scholars based in China, Macao and United States. Frequent co-authors include Yong Ling, Jianqiang Qian, Zhongyuan Xu, Peng Zhu, Chang‐Chun Ling, Guonian Wang, Jinlei Peng, Fude Feng, Weizhong Zhu and Yanan Zhang. Their work appears in journals such as European Journal of Medicinal Chemistry, Journal of Natural Products, Theranostics, Molecules and Journal of Medicinal Chemistry.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact